Voluntary announcement share repurchase
Filed with HKEX · Stock code 460 · · 2 pages · English
Summary by 6ix AI
Sihuan Pharmaceutical Holdings Group Ltd. has made a voluntary announcement regarding a share repurchase plan. The company intends to repurchase shares in the open market under a mandate granted by shareholders. On a specified date, the company repurchased a total of shares at an average price, intending to hold them as treasury shares for future use.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sihuan Pharmaceutical Holdings Group Ltd. on 6ix
Earlier from Sihuan Pharmaceutical
- Next Day Disclosure Return
- Voluntary announcement - new indication of xuanzhu biopharm's Bireociclib included in the 2026 NRDL
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement- phase III clinical study data of xuanzhu biopharm's Anaprazole Sodium for reflux esophagitis presented at UEG Week 2026
- Voluntary announcement - polycaprolactone microsphere facial filler for Injection and hyaluronic acid sodium composite solution for Injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kong
Follow Sihuan Pharmaceutical into a list and get an email when it puts out news.
Follow Sihuan Pharmaceutical